Accuracy: NIPT is more accurate in detecting certain chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), compared to the NT test.

Timing: NIPT can be done earlier in pregnancy, from 10 weeks, while the NT test is usually done between 12 and 14 weeks. This earlier timing can provide expectant parents with information sooner, which may be advantageous for decision-making.

Invasiveness: NIPT is non-invasive. As it only requires a blood sample from the mother it has no potential risks associated with invasive procedures.

Risk Stratification: Non-invasive prenatal testing (NIPT) provides risk stratification by estimating the probability that a fetus has specific chromosomal abnormalities based on the analysis of cell-free fetal DNA in maternal blood. It categorizes pregnancies into low-risk or high-risk groups.

Gender confirmation: Optional

Non-Invasive Prenatal Testing (NIPT) offers expectant parents a highly accurate, safe, and early way to assess their baby’s risk for common chromosomal conditions. With a simple maternal blood test from as early as 10 weeks, NIPT can detect over 99% of cases of Down syndrome (trisomy 21) and has excellent accuracy for trisomy 18 and trisomy 13, all while maintaining an extremely low false positive rate of less than 0.1%. Unlike traditional screening methods, NIPT provides clearer results sooner and poses no risk to you or your baby. For families seeking peace of mind and the ability to make informed choices early in pregnancy, NIPT is one of the most reliable and advanced screening options available today.

NIPT Blood test

Dating scan

4 Glossy Photographs

Video Download

Medical report

Midwifery consultation

Results are usually back between 3-5 working days